期刊文献+

基于PCR-LIS-SSCP的白念珠菌菌丝相与酵母相ERG11基因比较研究 被引量:2

A comparative study on the difference in the sequence of ERG11 gene between the yeast and hyphal form of Candida albicans by PCR-LIS-SSCP
原文传递
导出
摘要 目的通过对白念珠菌菌丝相与酵母相ERG11基因PCR-LIS-SSCP图谱的比较,探讨两相细胞在DNA水平的差异。方法分别抽提16株来自同一亲本且对氟康唑敏感性不同的白念珠菌菌丝相与酵母相基因组DNA,根据ERG11基因序列设计7对引物,对其进行分段PCR扩增,扩增产物经单链变性后,以非变性聚丙烯酰胺凝胶进行SSCP分析。结果16株白念珠菌菌丝相与酵母相均能扩增出目的片段,SSCP图谱显示两相细胞的ERG11基因序列存在多位点差异。结论白念珠菌菌丝相与酵母相ERG11,基因存在着差异。 Objective To investigate the difference of ERG11 gene between the yeast and hyphal forms of Candida albicans by PCR-LIS-SSCP ( low ionic strength single-strand conformation polymorphism ). Methods The genome DNA was extracted from the yeast and hyphal forms of 16 strains of C. albicans, which were isolated from a HIV-seropositive patient and showed different susceptibility to fluoconazole. ERGII gene was amplified by PCR with seven sets of primers. Then the PCR products were denatured and subjected to PCR-LIS-SSCP analysis. Results Seven fragments of the ERGI 1 gene were successfully amplified for both forms of all 16 strains. As shown by PCR-LIS-SSCP fingerprints, differences were observed in many sites of ERG11 gene between the two forms of C. albicans. Conclusion In general, differences exist in the ERG11 gene sequence between the hyphal form and yeast form of C.albicans.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2006年第7期377-380,共4页 Chinese Journal of Dermatology
基金 广东省科技计划项目(2004833101004)
关键词 念珠菌 白色 菌丝相 酵母相 ERG11基因 Candida albicans Hyphal form Yeast ERG11 gene
  • 相关文献

参考文献4

二级参考文献17

  • 1White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11: 382-402.
  • 2White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.
  • 3Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 4White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1: S102-109.
  • 5Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53: 565-572.
  • 6Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4: 728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30: 281-287.
  • 7Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287.
  • 8郭宁如,现代真菌病诊断治疗学,1997年,51页
  • 9Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS:documentation by in vitro susceptibility testing and DNA subtype analysis[J]. Clin Infect Dis, 1994,
  • 10White TC,Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient[J]. Oral Dis, 1997,3(suppl 1) : 102- 109.

共引文献34

同被引文献13

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部